Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zygmunt BM"'
Autor:
Dulak-Lis M; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Bujak A; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Gala K; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Banach M; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Kędzierska U; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Miszkiel J; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Hucz-Kalitowska J; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Mroczkiewicz M; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Stypik B; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Szymczak K; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Gunerka P; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Dubiel K; Celon Pharma S.A., Medicinal Chemistry Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Zygmunt BM; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland. Electronic address: beata.zygmunt@celonpharma.com., Wieczorek M; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland., Pieczykolan JS; Celon Pharma S.A., Preclinical Department, Mokra 41a, Kiełpin, 05-092, Łomianki, Poland.
Publikováno v:
Journal of pharmacological sciences [J Pharmacol Sci] 2021 Apr; Vol. 145 (4), pp. 340-348. Date of Electronic Publication: 2021 Feb 09.
Autor:
Gunerka P; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Gala K; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Banach M; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Dominowski J; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Hucz-Kalitowska J; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Mulewski K; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Hajnal A; LabMagister Training and Science Ltd., Budapest, Hungary., Mikus EG; LabMagister Training and Science Ltd., Budapest, Hungary., Smuga D; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Zagozda M; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Dubiel K; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Pieczykolan J; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Zygmunt BM; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland., Wieczorek M; CelonPharma Innovative Drugs Research & Development Department, Celon Pharma S.A., Lomianki, Poland.
Publikováno v:
PloS one [PLoS One] 2020 Jul 23; Vol. 15 (7), pp. e0236159. Date of Electronic Publication: 2020 Jul 23 (Print Publication: 2020).
Autor:
Zygmunt BM; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany; beata.zygmunt@helmholtz-hzi.de.; Wroclaw Research Center EIT+, 54-066 Wroclaw, Poland., Węgrzyn A; Wroclaw Research Center EIT+, 54-066 Wroclaw, Poland., Gajska W; Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Technology, 50-377 Wroclaw, Poland; and., Yevsa T; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625 Hannover, Germany., Chodaczek G; Wroclaw Research Center EIT+, 54-066 Wroclaw, Poland., Guzmán CA; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Sep 01; Vol. 201 (5), pp. 1400-1411. Date of Electronic Publication: 2018 Jul 20.
Autor:
Zygmunt BM; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany. beata.zygmunt@bbsrc.ac.uk, Weissmann SF, Guzman CA
Publikováno v:
PloS one [PLoS One] 2012; Vol. 7 (1), pp. e30382. Date of Electronic Publication: 2012 Jan 26.
Autor:
Zygmunt BM; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Groebe L, Guzman CA
Publikováno v:
PloS one [PLoS One] 2011; Vol. 6 (7), pp. e18032. Date of Electronic Publication: 2011 Jul 18.
Autor:
Zygmunt BM; Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany. beata.zygmunt@helmholtz-hzi.de, Rharbaoui F, Groebe L, Guzman CA
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2009 Dec 01; Vol. 183 (11), pp. 6933-8. Date of Electronic Publication: 2009 Nov 04.